Aytu Biopharma Inc (AYTU) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Aytu Biopharma Inc  (NASDAQ: AYTU)
 

Aytu Biopharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aytu Biopharma Inc inventory turnover ratio, the Aytu Biopharma Inc's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.02 in the third quarter 2026, yet the ratio remained below the average, as AYTU's market remain challenging.Average inventory processing period, for the Aytu Biopharma Inc in Mar 31 2026 quarter, has decreased to 181 days, compare to 188 days, in the Dec 31 2025 quarter.

Within Healthcare sector 202 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1408 in the second quarter 2026, to 1456.

AYTU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aytu Biopharma Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AYTU Inventory Turnover Ratio (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter		 (Mar 31 2025)
III. Quarter
Y / Y Inventory Growth -32.54 % -21.91 % -13.96 % -9.49 % -16.18 %
Y / Y Cost of Sales Growth -20 % 0 % 0 % -14.29 % -16.67 %
Inventory Turnover Ratio (TTM) 2.02 1.94 1.83 1.77 1.81
AYTU's Total Ranking # 1456 # 1408 # 1408 # 1444 # 1195
Average inventory processing period 181 188 199 207 202
Seq. Inventory Growth -13.82 % -14.3 % -11.67 % 3.4 % -0.24 %
Seq. Cost of Sales Growth -20 % 25 % -33.33 % 20 % 0 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 59
Healthcare Sector # 203
Overall Market # 1456

Inventory Turnover Ratio Statistics
High Average Low
3.38 2.1 0.9
(Dec 31 2022)   (Sep 30 2015)



AYTU Company Profile >> Back to AYTU Efficiency Comparisons >> Compare AYTU Inventory Turnover Ratio to its Competitors

Financial Statements
Aytu Biopharma Inc's Inventories $ 7 Millions Visit AYTU's Balance sheet
Aytu Biopharma Inc's Cost of Revenues TTM $ 19 Millions Visit AYTU's Income Statement
What are AYTU's Sales? Visit AYTU's Sales by Segment

Other Inventory Turnover Ratios
Aytu Biopharma Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AYTU's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AYTU's Competitors
Inventory Turnover Ratio for AYTU's Suppliers
Inventory Turnover Ratio for AYTU's Customers

You may also want to know
AYTU's Sales Growth Rates AYTU's Pe Price to earnings ratio AYTU's Receivables Turnover Ratio AYTU's Stock Quote
AYTU's Net Income Growth Rates AYTU's Ps Price to Sales ratio AYTU's Sales per Employee AYTU's Asset Turnover Ratio
AYTU's Net Margin AYTU's Pb Price to Book ratio AYTU's Financial Strength Ratios AYTU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions

Date modified: 2026-08-29T17:22:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.